KellyNicoleFitzgeraldMD

PubMed

• 5 citations
  Adjuvant therapy options in renal cell carcinoma - targeting the metastatic cascade.
  Kelly N Fitzgerald, Robert J Motzer, Chung-Han Lee> ;Nature Reviews. Urology. 2023 Mar 1
• 5 citations
  Progression-free Survival After Second Line of Therapy for Metastatic Clear Cell Renal Cell Carcinoma in Patients Treated with First-line Immunotherapy Combinations.
  Kelly N Fitzgerald, Cihan Duzgol, Andrea Knezevic, Natalie Shapnik, Ritesh Kotecha, David H Aggen, Maria I Carlo, Neil J Shah, Martin H Voss, Darren R Feldman, Robert ...> ;European Urology. 2023 Mar 1
• 7 citations
  Personalizing First-Line Management of Metastatic Renal Cell Carcinoma: Leveraging Current and Novel Therapeutic Options.
  Kelly N Fitzgerald, Chung-Han Lee> ;Journal of the National Comprehensive Cancer Network. 2022 Apr 6
• 8 citations
  Genomic and Metabolic Hallmarks of SDH- and FH-deficient Renal Cell Carcinomas.
  Angela Yoo, Cerise Tang, Mark Zucker, Kelly Fitzgerald, Renzo G DiNatale, Phillip M Rappold, Kate Weiss, Benjamin Freeman, Chung-Han Lee, Nikolaus Schultz, Robert Motz...> ;European Urology Focus. 2022 Sep 1
• 8 citations
  CD19 epitope masking by tafasitamab leads to delays in subsequent use of CD19 CAR T-cell therapy in two patients with aggressive mature B-cell lymphomas.
  Kelly N Fitzgerald, Andres E Quesada, Gottfried von Keudell, Sandeep Raj, Natasha E Lewis, Ahmet Dogan, Gilles Salles, M Lia Palomba> ;Leukemia & Lymphoma. 2022 Mar 1
• 6 citations
  Isoform specific anti-TGFβ therapy enhances antitumor efficacy in mouse models of cancer.
  Aditi Gupta, Sadna Budhu, Kelly Fitzgerald, Rachel Giese, Adam O. Michel, Aliya Holland, Luis Felipe Campesato, Jacques Van Snick, Catherine Uyttenhove, Gerd Ritter, T...> ;Communications Biology. 2021 Nov 17
• Join now to see all

Lectures

• Response to PD-1 inhibition in early- and late-relapsing cutaneous melanoma. 
  2019 ASCO Annual Meeting - 6/1/2019